GRAF ACQUISITION PARTNERS IV LLC (Chief Executive Officer) reported 1 transaction at NKGEN BIOTECH, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/26/2024ACC: 0001213900-24-112773
Officer10% Owner· Chief Executive Officer
Since May 2021
-914.91K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
914.91K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−63.63K
Price / share
—
Trade value
—
% of position
3.0%
12/20/2024
2.15M→2.08M
Total
Net shares
−63.63K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/20/2024 | J · J | −63.63K | — | — | 3.0% | 2.15M | 2.08M |
| Total | −63.63K | $0.00 | ||||||
Derivative Transactions2
Private Placement Warrants
Direct
Converts to
Common Stock
757.94K shares
Shares
−757.94K
Strike price
11.50
Held after
1.15M
Exercisable
—
12/20/2024
Working Capital Warrants
Direct
Converts to
Common Stock
93.33K shares
Shares
−93.33K
Strike price
11.50
Held after
96.47K
Exercisable
—
12/20/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Private Placement Warrants Direct | Common Stock757.94K shares | 12/20/2024 | D · Disposition | −757.94K | 11.50 | — | 1.15M |
| Working Capital Warrants Direct | Common Stock93.33K shares | 12/20/2024 | D · Disposition | −93.33K | 11.50 | — | 96.47K |